Medtronic Plc Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Medtronic Plc on March 7, 2023, reporting events occurring on March 2, 2023. The filing serves to notify shareholders of the date for the 2023 Annual General Meeting of Shareholders and to establish revised deadlines for shareholder proposals and director nominations.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is administrative in nature and does not contain financial performance data.
Material Changes
The primary material change is the scheduling of the 2023 Annual General Meeting for October 19, 2023. Because this date differs by more than 30 days from the anniversary of the 2022 meeting, the standard deadlines for shareholder proposals under Rule 14a-8 and director nominations no longer apply. Consequently, the Company has established new submission windows.
Guidance, Outlook, and Governance Deadlines
- Meeting Date: Thursday, October 19, 2023.
- Record Date: Friday, August 25, 2023 (close of trading on the NYSE).
- Rule 14a-8 Proposals: Must be submitted in writing before the close of business in Dublin, Ireland on Wednesday, May 10, 2023.
- Other Proposals/Nominations: Notices must be submitted no earlier than July 21, 2023, and no later than August 30, 2023 (Dublin time).
- Submission Address: 20 on Hatch, Lower Hatch Street, Dublin 2, D92 XH02, Ireland, Attn: Company Secretary.
Investor Verification Checklist
- Verify the record date of August 25, 2023, to confirm eligibility to vote at the October 19, 2023, meeting.
- Confirm the May 10, 2023, deadline for submitting proposals intended for inclusion in the proxy statement.
- Review the Articles of Association for specific content requirements for director nominations and non-14a-8 proposals.
- Note that the filing does not contain financial results; refer to the most recent 10-Q or 10-K for financial metrics.